Fifth Third Bancorp Eli Lilly & CO Transaction History

Fifth Third Bancorp

$26.1 Billion
Q2 2024

A detailed history of Fifth Third Bancorp transactions in Eli Lilly & CO stock. As of the latest transaction made, Fifth Third Bancorp holds 445,222 shares of LLY stock, worth $391 Million. This represents 1.55% of its overall portfolio holdings.

Number of Shares

445,222

Previous 413,568 7.65%

Holding current value

$391 Million

Previous $322 Million 25.29%

% of portfolio

1.55%

Previous 1.27%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 22, 2024	BUY	$724.87 - $909.04 $22.9 Million - $28.8 Million	31,654 Added 7.65%	445,222 $403 Million
Q1 2024 Apr 23, 2024	BUY	$592.2 - $792.28 $12.6 Million - $16.9 Million	21,352 Added 5.44%	413,568 $322 Million
Q4 2023 Jan 19, 2024	BUY	$525.19 - $619.13 $13.4 Million - $15.8 Million	25,492 Added 6.95%	392,216 $229 Million
Q3 2023 Oct 31, 2023	BUY	$434.7 - $599.3 $124,324 - $171,399	286 Added 0.08%	366,724 $197 Million
Q2 2023 Jul 25, 2023	BUY	$350.74 - $468.98 $44.2 Million - $59.1 Million	126,074 Added 52.45%	366,438 $172 Million
Q1 2023 Apr 24, 2023	BUY	$310.63 - $364.82 $7.13 Million - $8.37 Million	22,944 Added 10.55%	240,364 $82.5 Million
Q4 2022 Jan 25, 2023	BUY	$321.55 - $374.67 $4.9 Million - $5.7 Million	15,226 Added 7.53%	217,420 $0
Q3 2022 Oct 25, 2022	BUY	$296.48 - $337.87 $1.09 Million - $1.24 Million	3,668 Added 1.85%	202,194 $65.4 Million
Q2 2022 Aug 04, 2022	BUY	$278.73 - $327.27 $5.63 Million - $6.61 Million	20,204 Added 11.33%	198,526 $64.4 Million
Q1 2022 Apr 19, 2022	BUY	$234.69 - $291.66 $3.05 Million - $3.79 Million	13,003 Added 7.87%	178,322 $51.1 Million
Q4 2021 Feb 01, 2022	BUY	$224.85 - $279.04 $3.36 Million - $4.17 Million	14,950 Added 9.94%	165,319 $45.7 Million
Q3 2021 Oct 15, 2021	SELL	$221.6 - $272.71 $19,279 - $23,725	-87 Reduced 0.06%	150,369 $34.7 Million
Q2 2021 Aug 06, 2021	SELL	$180.55 - $233.54 $31,957 - $41,336	-177 Reduced 0.12%	150,456 $34.5 Million
Q1 2021 May 07, 2021	SELL	$164.32 - $212.72 $20,704 - $26,802	-126 Reduced 0.08%	150,633 $28.1 Million
Q4 2020 Feb 16, 2021	SELL	$130.46 - $172.63 $2.05 Million - $2.72 Million	-15,734 Reduced 9.45%	150,759 $25.5 Million
Q3 2020 Nov 09, 2020	BUY	$146.22 - $169.13 $2.2 Million - $2.55 Million	15,063 Added 9.95%	166,493 $24.6 Million
Q2 2020 Aug 05, 2020	BUY	$136.42 - $164.18 $3.98 Million - $4.8 Million	29,208 Added 23.9%	151,430 $24.9 Million
Q1 2020 May 05, 2020	BUY	$119.05 - $147.35 $1.39 Million - $1.72 Million	11,650 Added 10.54%	122,222 $17 Million
Q4 2019 Feb 14, 2020	SELL	$106.92 - $132.43 $53,139 - $65,817	-497 Reduced 0.45%	110,572 $14.5 Million
Q3 2019 Nov 14, 2019	SELL	$106.79 - $116.16 $75,180 - $81,776	-704 Reduced 0.63%	111,069 $12.4 Million
Q2 2019 Aug 07, 2019	BUY	$110.79 - $129.32 $611,560 - $713,846	5,520 Added 5.2%	111,773 $12.4 Million
Q1 2019 May 14, 2019	SELL	$111.31 - $131.02 $1.01 Million - $1.19 Million	-9,052 Reduced 7.85%	106,253 $13.8 Million
Q4 2018 Feb 14, 2019	SELL	$105.9 - $118.64 $698,622 - $782,668	-6,597 Reduced 5.41%	115,305 $13.3 Million
Q3 2018 Nov 14, 2018	BUY	$85.86 - $107.31 $1.2 Million - $1.5 Million	13,985 Added 12.96%	121,902 $13.1 Million
Q2 2018 Aug 14, 2018	BUY	$75.7 - $86.88 $366,993 - $421,194	4,848 Added 4.7%	107,917 $9.21 Million
Q1 2018 May 15, 2018	SELL	$74.21 - $87.6 $287,786 - $339,712	-3,878 Reduced 3.63%	103,069 $7.97 Million
Q4 2017 Feb 14, 2018	SELL	$81.94 - $87.89 $233,365 - $250,310	-2,848 Reduced 2.59%	106,947 $9.03 Million
Q3 2017 Nov 14, 2017	SELL	$77.07 - $85.54 $99,651 - $110,603	-1,293 Reduced 1.16%	109,795 $9.39 Million
Q2 2017 Aug 11, 2017	BUY	N/A	111,088	111,088 $9.14 Million

Others Institutions Holding LLY

# of Institutions

3,872

Shares Held

751M

Call Options Held

6.34M

Put Options Held

7.97M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $834B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fifth Third Bancorp, based on Form 13F filings with the SEC.

News

Stay updated on Fifth Third Bancorp with notifications on news.

Account

Fifth Third Bancorp Eli Lilly & CO Transaction History